BeiGene (Brazil) Today

BeiGene is trading at 66.48 as of the 17th of March 2025, a 0.73% up since the beginning of the trading day. The stock's open price was 66.0. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Valuation
Check how we calculate scores

BeiGene Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BeiGene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BeiGene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
BeiGene (B1GN34) is traded on Sao Paulo Exchange in Brazil and employs 9,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 134.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BeiGene's market, we take the total number of its shares issued and multiply it by BeiGene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BeiGene operates under Healthcare sector and is part of Biotechnology industry. The entity has 1.35 B outstanding shares. BeiGene generates negative cash flow from operations
Check BeiGene Probability Of Bankruptcy

BeiGene Risk Profiles

Although BeiGene's alpha and beta are two of the key measurements used to evaluate BeiGene's performance over the market, the standard measures of volatility play an important role as well.

BeiGene Stock Against Markets

BeiGene Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BeiGene stock to make a market-neutral strategy. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

BeiGene Corporate Management

Elected by the shareholders, the BeiGene's board of directors comprises two types of representatives: BeiGene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BeiGene. The board's role is to monitor BeiGene's management team and ensure that shareholders' interests are well served. BeiGene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BeiGene's outside directors are responsible for providing unbiased perspectives on the board's policies.
John OylerEx CoFounderProfile
Xiaodong WangChairman CoFounderProfile
Mi ZhouDirector RelationsProfile
Daniel MallerVP AccountingProfile
Chan LeeG CounselProfile
Wang LaiGlobal RDProfile
Kevin MannixVP RelationsProfile

Other Information on Investing in BeiGene Stock

BeiGene financial ratios help investors to determine whether BeiGene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BeiGene with respect to the benefits of owning BeiGene security.